|
|
|
|
|
|
|
¸ñÂ÷ |
|
ÃßõÀÇ ±Û
Ã¥ ¸Ó¸®¿¡
123 Antihistamine
124 Mast cell stabilizers
125 ºñ°³» ½ºÅ×·ÎÀ̵åÁ¦ intranasal corticosteroids
126 Type 2 histamine receptor antagonist
127 Cyanocobalamine
128 °³·®½Å¾à (Incrementally Modified Drug£ºIMD)
129 Radiopharmaceuticals (¹æ»ç¼º ÀǾàǰ)
130 Advanced dressing
131 DNA virus, RNA virus
132 AÇü °£¿°
133 BÇü °£¿°
134 CÇü °£¿°
135 Lithium carbonate
136 Selective Estrogen Receptor Modulator(SERMs)
137 Aromatase inhibitor
138 Progestin °ü·Ã¾à¹°
139 Àü¸³¼±¾Ï °ü·Ã ¾à¹°
140 Prostaglandin °ü·Ã ¾à¹°
141 Praziquantel, Albendazole ±×¸®°í Niclosamide
142 Blood coagulation factor
143 Vitamin K
144 Tranexamic acid(µµ¶õ»ç¹Î)
145 Heparin
146 Warfarin
147 New Oral Anti Coagulant (NOAC)
148 ¼¹æÇü Á¦Á¦
149 Gargle ¹× ¼¼Á¤Á¦
150 Alkylating antineoplastic agent
151 Platinum Ç×¾ÏÁ¦
152 Antimetabolites °ü·Ã ¾à¹°
153 Antitumor Antibiotics
154 ½Ä¹°À» ÀÌ¿ëÇÑ Ç×¾ÏÁ¦
155 ±âŸ Ç×¾ÏÁ¦
156 Mistletoe(¹Ì½½Åä)
157 P-glycoprotein ¾à¹° ¼ö¼Û´Ü¹é
158 Salicylic acid¿Í ¿°Áõ¼º ÀåÁúȯ ¾à¹°
159 º¯ºñ °ü·Ã ¾à¹°
160 Alpha adrenergic receptor
161 Beta È¿ÇöÁ¦
162 Carotenoids
163 Flavonoids
164 Flavonoid ÀǾàǰ
165 Á¤À¯(ïñêú, essential oil)¾à¹°
166 À̸§ÀÌ È¿´ÉÀ» ¸»ÇÏ´Â º»ÃÊ(Üâõ®)
167 ¾¦°ú ¾î¼ºÃÊ(åàá£õ®)
168 ¸¶(Ø«), õ(ô¸)ÀÌ µé¾î°£ º»ÃÊ(Üâõ®)
169 Çà(úº)°ú ñÓ(´ë³ª¹«)
170 ¶¥ Áö(ò¢)°¡ µé¾î°£ º»ÃÊ(Üâõ®)
171 °ÀåÁ¦ ¸¶(ߣå·), »ê¼öÀ¯
172 Çâ(úÅ)
173 ÀÚÇϰÅ(í¹ùÁËç)
174 ¸ÀÀ» Ç¥ÇöÇÑ º»ÃÊ(Üâõ®)
175 ¸ð½ÀÀÌ °ð À̸§ÀÎ º»ÃÊ(Üâõ®)
176 19±Ý º»ÃÊ(Üâõ®)
INDEX |
|
|
|
|
|
|
|
Ãâ°í¾È³» |
|
 |
Ãâ°í¶õ ÀÎÅÍÆÄÅ© ¹°·ùâ°í¿¡¼ µµ¼°¡ Æ÷ÀåµÇ¾î ³ª°¡´Â ½ÃÁ¡À» ¸»Çϸç, ½ÇÁ¦ °í°´´Ô²²¼ ¼ö·ÉÇϽô ½Ã°£Àº »óǰÁغñ¿Ï·áÇØ Ãâ°íÇÑ ³¯Â¥ + Åùè»ç ¹è¼ÛÀÏÀÔ´Ï´Ù. |
 |
ÀÎÅÍÆÄÅ© µµ¼´Â ¸ðµç »óǰÀÇ Àç°í°¡ ÃæÁ·ÇÒ ½Ã¿¡ Àϰý Ãâ°í¸¦ ÇÕ´Ï´Ù. |
 |
ÀϺΠÀç°í¿¡ ´ëÇÑ Ãâ°í°¡ ÇÊ¿äÇÒ ½Ã¿¡´Â ´ã´çÀÚ¿¡°Ô Á÷Á¢ ¿¬¶ôÇϽðųª, °í°´¼¾ÅÍ(°í°´¼¾ÅÍ(1577-2555)·Î ¿¬¶ôÁֽñ⠹ٶø´Ï´Ù. |
|
¹è¼Ûºñ ¾È³» |
|
 |
ÀÎÅÍÆÄÅ© µµ¼ ´ë·®±¸¸Å´Â ¹è¼Û·á°¡ ¹«·áÀÔ´Ï´Ù. |
 |
´Ü, 1°³ÀÇ »óǰÀ» ´Ù¼öÀÇ ¹è¼ÛÁö·Î Àϰý ¹ß¼Û½Ã¿¡´Â 1°³ÀÇ ¹è¼ÛÁö´ç 2,000¿øÀÇ ¹è¼Ûºñ°¡ ºÎ°úµË´Ï´Ù. |
¾Ë¾ÆµÎ¼¼¿ä! |
|
 |
°í°´´Ô²²¼ ÁÖ¹®ÇϽеµ¼¶óµµ µµ¸Å»ó ¹× ÃâÆÇ»ç »çÁ¤¿¡ µû¶ó ǰÀý/ÀýÆÇ µîÀÇ »çÀ¯·Î Ãë¼ÒµÉ ¼ö ÀÖ½À´Ï´Ù. |
 |
Åùè»ç ¹è¼ÛÀÏÀÎ ¼¿ï ¹× ¼öµµ±ÇÀº 1~2ÀÏ, Áö¹æÀº 2~3ÀÏ, µµ¼, »ê°£, ±ººÎ´ë´Â 3ÀÏ ÀÌ»óÀÇ ½Ã°£ÀÌ ¼Ò¿äµË´Ï´Ù.
(´Ü, Åä/ÀÏ¿äÀÏ Á¦¿Ü) |
|
|
|
|
ÀÎÅÍÆÄÅ©µµ¼´Â °í°´´ÔÀÇ ´Ü¼ø º¯½É¿¡ ÀÇÇÑ ±³È¯°ú ¹Ýǰ¿¡ µå´Â ºñ¿ëÀº °í°´´ÔÀÌ ÁöºÒÄÉ µË´Ï´Ù.
´Ü, »óǰÀ̳ª ¼ºñ½º ÀÚüÀÇ ÇÏÀÚ·Î ÀÎÇÑ ±³È¯ ¹× ¹ÝǰÀº ¹«·á·Î ¹Ýǰ µË´Ï´Ù.
±³È¯/¹Ýǰ/º¸ÁõÁ¶°Ç ¹× ǰÁúº¸Áõ ±âÁØÀº ¼ÒºñÀڱ⺻¹ý¿¡ µû¸¥ ¼ÒºñÀÚ ºÐÀï ÇØ°á ±âÁØ¿¡ µû¶ó ÇÇÇØ¸¦ º¸»ó ¹ÞÀ» ¼ö ÀÖ½À´Ï´Ù.
Á¤È®ÇÑ È¯ºÒ ¹æ¹ý ¹× ȯºÒÀÌ Áö¿¬µÉ °æ¿ì 1:1¹®ÀÇ °Ô½ÃÆÇ ¶Ç´Â °í°´¼¾ÅÍ(1577-2555)·Î ¿¬¶ô Áֽñ⠹ٶø´Ï´Ù.
¼ÒºñÀÚ ÇÇÇØº¸»óÀÇ ºÐÀïó¸® µî¿¡ °üÇÑ »çÇ×Àº ¼ÒºñÀÚºÐÀïÇØ°á±âÁØ(°øÁ¤°Å·¡À§¿øÈ¸ °í½Ã)¿¡ µû¶ó ºñÇØ º¸»ó ¹ÞÀ» ¼ö ÀÖ½À´Ï´Ù.
|
±³È¯ ¹× ¹ÝǰÀÌ °¡´ÉÇÑ °æ¿ì |
|
 |
»óǰÀ» °ø±Þ ¹ÞÀ¸½Å ³¯·ÎºÎÅÍ 7ÀÏÀ̳» °¡´ÉÇÕ´Ï´Ù. |
 |
°ø±Þ¹ÞÀ¸½Å »óǰÀÇ ³»¿ëÀÌ Ç¥½Ã, ±¤°í ³»¿ë°ú ´Ù¸£°Å³ª ´Ù¸£°Ô ÀÌÇàµÈ °æ¿ì¿¡´Â °ø±Þ¹ÞÀº ³¯·ÎºÎÅÍ 3°³¿ùÀ̳», ±×»ç½ÇÀ» ¾Ë°Ô µÈ ³¯ ¶Ç´Â ¾Ë ¼ö ÀÖ¾ú´ø ³¯·ÎºÎÅÍ 30ÀÏÀ̳» °¡´ÉÇÕ´Ï´Ù. |
 |
»óǰ¿¡ ¾Æ¹«·± ÇÏÀÚ°¡ ¾ø´Â °æ¿ì ¼ÒºñÀÚÀÇ °í°´º¯½É¿¡ ÀÇÇÑ ±³È¯Àº »óǰÀÇ Æ÷Àå»óÅ µîÀÌ ÀüÇô ¼Õ»óµÇÁö ¾ÊÀº °æ¿ì¿¡ ÇÑÇÏ¿© °¡´ÉÇÕ´Ï´Ù.
|
|
|
|
±³È¯ ¹× ¹ÝǰÀÌ ºÒ°¡´ÉÇÑ °æ¿ì |
|
|
 |
°í°´´ÔÀÇ Ã¥ÀÓ ÀÖ´Â »çÀ¯·Î »óǰ µîÀÌ ¸ê½Ç ¶Ç´Â ÈÑ¼ÕµÈ °æ¿ì´Â ºÒ°¡´ÉÇÕ´Ï´Ù. (´Ü, »óǰÀÇ ³»¿ëÀ» È®ÀÎÇϱâ À§ÇÏ¿© Æ÷Àå µîÀ» ÈѼÕÇÑ °æ¿ì´Â Á¦¿Ü) |
 |
½Ã°£ÀÌ Áö³²¿¡ µû¶ó ÀçÆÇ¸Å°¡ °ï¶õÇÒ Á¤µµ·Î ¹°Ç°ÀÇ °¡Ä¡°¡ ¶³¾îÁø °æ¿ì´Â ºÒ°¡´ÉÇÕ´Ï´Ù. |
 |
Æ÷Àå °³ºÀµÇ¾î »óǰ °¡Ä¡°¡ ÈÑ¼ÕµÈ °æ¿ì´Â ºÒ°¡´ÉÇÕ´Ï´Ù. |
|
|
´Ù¹è¼ÛÁöÀÇ °æ¿ì ¹Ýǰ ȯºÒ |
|
|
 |
´Ù¹è¼ÛÁöÀÇ °æ¿ì ´Ù¸¥ Áö¿ªÀÇ ¹ÝǰÀ» µ¿½Ã¿¡ ÁøÇàÇÒ ¼ö ¾ø½À´Ï´Ù. |
 |
1°³ Áö¿ªÀÇ ¹ÝǰÀÌ ¿Ï·áµÈ ÈÄ ´Ù¸¥ Áö¿ª ¹ÝǰÀ» ÁøÇàÇÒ ¼ö ÀÖÀ¸¹Ç·Î, ÀÌÁ¡ ¾çÇØÇØ Áֽñ⠹ٶø´Ï´Ù. |
|
|
|
|
|
|